Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (SHE: 300760)
China
· Delayed Price · Currency is CNY 270.68
-5.92 (-2.14%)
Nov 15, 2024, 3:04 PM CST
Shenzhen Mindray Bio-Medical Electronics Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | 12,385 | 11,582 | 9,607 | 8,002 | 6,658 | 4,681 | Upgrade
|
| Depreciation & Amortization | 978.4 | 978.4 | 885.06 | 700.41 | 472.12 | 394.31 | Upgrade
|
| Other Amortization | 60.77 | 60.77 | 26.31 | 16.65 | 10.96 | 11.04 | Upgrade
|
| Loss (Gain) From Sale of Assets | -2.46 | -2.46 | -6.16 | -4.07 | 2.07 | 1.49 | Upgrade
|
| Asset Writedown & Restructuring Costs | 274.92 | 274.92 | 0.74 | 0.62 | 16.87 | 112.59 | Upgrade
|
| Loss (Gain) From Sale of Investments | -69.56 | -69.56 | 5.06 | -0.81 | 4.47 | - | Upgrade
|
| Provision & Write-off of Bad Debts | 244.18 | 244.18 | 36.78 | -5.94 | 29.64 | 8.75 | Upgrade
|
| Other Operating Activities | 2,533 | 33.63 | -145.31 | -103.06 | 354.27 | 41.49 | Upgrade
|
| Change in Accounts Receivable | -680.91 | -680.91 | -1,047 | -153.44 | -3.27 | -312.25 | Upgrade
|
| Change in Inventory | -201.43 | -201.43 | -523.01 | -133.63 | -1,448 | -706.74 | Upgrade
|
| Change in Accounts Payable | -769.19 | -769.19 | 3,094 | 615.09 | 2,827 | 553.59 | Upgrade
|
| Change in Other Net Operating Assets | 253.87 | 253.87 | 382.89 | 5.4 | - | -13.96 | Upgrade
|
| Operating Cash Flow | 14,364 | 11,062 | 12,141 | 8,999 | 8,870 | 4,722 | Upgrade
|
| Operating Cash Flow Growth | 9.07% | -8.89% | 34.92% | 1.45% | 87.85% | 17.03% | Upgrade
|
| Capital Expenditures | -2,124 | -2,689 | -1,916 | -1,402 | -1,183 | -776.86 | Upgrade
|
| Sale of Property, Plant & Equipment | 23.14 | 21.66 | 73.33 | 21.73 | 2.83 | 3.9 | Upgrade
|
| Cash Acquisitions | -6,644 | -870.82 | - | -3,520 | - | - | Upgrade
|
| Investment in Securities | 3,862 | 2,689 | -1,558 | - | -4,020 | -5 | Upgrade
|
| Other Investing Activities | 1,770 | 156.15 | 180.02 | 88.32 | 8.75 | - | Upgrade
|
| Investing Cash Flow | -3,112 | -692.93 | -3,220 | -4,812 | -5,191 | -777.97 | Upgrade
|
| Total Debt Issued | 2.41 | - | - | - | - | - | Upgrade
|
| Long-Term Debt Repaid | - | -142.46 | -103.35 | -537.94 | - | - | Upgrade
|
| Total Debt Repaid | -147.57 | -142.46 | -103.35 | -537.94 | - | - | Upgrade
|
| Net Debt Issued (Repaid) | -145.16 | -142.46 | -103.35 | -537.94 | - | - | Upgrade
|
| Issuance of Common Stock | - | - | 152.43 | - | - | - | Upgrade
|
| Repurchase of Common Stock | -6.08 | -6.08 | -999.94 | -999.99 | - | - | Upgrade
|
| Common Dividends Paid | -11,955 | -10,670 | -4,233 | -3,039 | -1,824 | -1,216 | Upgrade
|
| Other Financing Activities | 64.99 | 42.47 | -10.54 | -27.71 | -29.59 | -25.88 | Upgrade
|
| Financing Cash Flow | -12,041 | -10,776 | -5,194 | -4,605 | -1,853 | -1,242 | Upgrade
|
| Foreign Exchange Rate Adjustments | -164.43 | 101.37 | 113.82 | -171.45 | -197.47 | 23.65 | Upgrade
|
| Net Cash Flow | -953.37 | -305.22 | 3,841 | -589.78 | 1,628 | 2,726 | Upgrade
|
| Free Cash Flow | 12,241 | 8,373 | 10,226 | 7,596 | 7,687 | 3,945 | Upgrade
|
| Free Cash Flow Growth | 15.61% | -18.11% | 34.62% | -1.19% | 94.87% | 17.54% | Upgrade
|
| Free Cash Flow Margin | 32.98% | 23.97% | 33.67% | 30.06% | 36.56% | 23.83% | Upgrade
|
| Free Cash Flow Per Share | 10.10 | 6.91 | 8.45 | 6.25 | 6.32 | 3.25 | Upgrade
|
| Cash Income Tax Paid | 3,226 | 3,100 | 2,712 | 2,069 | 1,605 | 1,644 | Upgrade
|
| Levered Free Cash Flow | 8,103 | 3,873 | 7,485 | 4,887 | 5,715 | 2,470 | Upgrade
|
| Unlevered Free Cash Flow | 8,114 | 3,881 | 7,492 | 4,893 | 5,715 | 2,470 | Upgrade
|
| Change in Net Working Capital | -555.21 | 2,350 | -1,682 | -100.72 | -1,878 | 279.12 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.